PRC drug maker issues CBs on the Singapore Exchange

    | BY

    clpstaff &clp articles

    China-based pharmaceuticals company The United Laboratories International Holdings (United Laboratories) issued Rmb790 million (US$123.84 million) US-dollar…

    China-based pharmaceuticals company The United Laboratories International Holdings (United Laboratories) issued Rmb790 million (US$123.84 million) US-dollar settled 7.5% convertible bonds (CBs) due 2016. The CBs are listed on the Singapore Stock Exchange and have an additional upsize option of Rmb200 million.

    The lead manager of the offering was HSBC.

    This premium content is reserved for
    China Law & Practice Subscribers.

    • A database of over 3,000 essential documents including key PRC legislation translated into English
    • A choice of newsletters to alert you to changes affecting your business including sector specific updates
    • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
    For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]